Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mismatch Repair

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An n-of-1 gene-directed drug repurposing trial for an ultrarare genetic condition.

Epilepsia·2026

Same author

ABCA4 Versus PRPH2-Associated Retinopathy: Clinical and Electrophysiological Findings.

Investigative ophthalmology & visual science·2026

Same author

Broadening the phenotypic and molecular spectrum of PRS deficiency in females.

HGG advances·2026

Same author

Loss of RPGR disrupts motile cilia and causes primary ciliary dyskinesia by affecting F-actin dynamics.

The Journal of clinical investigation·2026

Same author

A novel phenotype-guided genome analysis pipeline for variant discovery.

NPJ genomic medicine·2026

Same author

Gene therapy outcomes in young patients with RPE65-retinal degeneration.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026

Same journal

Bardet-Biedl syndrome in a Chinese patient with a novel homozygous <i>BBS5</i> variant from paternal uniparental disomy.

Ophthalmic genetics·2026

Same journal

Choroidal melanoma and polydactylous onychopapilloma leading to diagnosis of <i>BAP1</i> tumor predisposition syndrome.

Ophthalmic genetics·2026

Same journal

Ora visual navigation course™ mobility test results in two individuals with <i>CEP290</i> LCA after intravitreal injection of antisense oligonucleotide.

Ophthalmic genetics·2026

Same journal

Novel ATF6 luminal domain variant in Achromatopsia.

Ophthalmic genetics·2026

Same journal

Absent cone function and stable ophthalmic features in a non-syndromic woman with pathogenic variants in <i>CEP290</i>.

Ophthalmic genetics·2026

Same journal

Expanding the phenotypic and genotypic spectrum of <i>TENM3</i>-related syndromic microphthalmia.

Ophthalmic genetics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Published on: February 3, 2023

BBS mutational analysis: a strategic approach.

Gail Billingsley¹, Catherine Deveault, Elise Héon

¹Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.

Ophthalmic Genetics

|April 6, 2011

Summary

This summary is machine-generated.

This study optimizes mutation detection for Bardet-Biedl syndrome (BBS), a rare genetic disorder. Pooling data and targeted screening of key genes (BBS1, BBS10, BBS2, BBS12) significantly improves diagnostic efficiency and cost-effectiveness.

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Experiment Videos

Last Updated: Jun 3, 2026

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Published on: February 3, 2023

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Area of Science:

Genetics
Molecular Biology
Rare Diseases

Background:

Bardet-Biedl syndrome (BBS) is a rare, autosomal recessive disorder with significant genetic heterogeneity, involving at least 15 identified genes.
The extensive coding sequence of BBS genes presents challenges for cost-effective mutational analysis.

Purpose of the Study:

To optimize a mutation screening strategy for Bardet-Biedl syndrome by analyzing a large cohort and published literature.
To provide a comprehensive tabulation of BBS1-BBS12 mutant alleles.

Main Methods:

Retrospective analysis of mutational data from 83 BBS families and literature published up to September 2010.
Development of a mutation screening strategy based on the distribution and frequency of identified BBS alleles.
Utilized targeted sequencing and simple screening methods like restriction enzyme digest and ARMS assay for recurrent mutations.

Main Results:

Identified disease-causing alleles in 76% of probands, with BBS1, BBS2, BBS10, and BBS12 accounting for 82.4% of published alleles.
A strategy focusing on recurrent mutations (e.g., BBS1 M390R, BBS10 C91LfsX5) and frequently involved exons in the top 4 genes increased detection rates.
The 16 most frequent alleles could be identified efficiently using basic screening methods, minimizing the need for extensive sequencing.

Conclusions:

Pooling data from multiple centers is beneficial for analyzing rare, genetically heterogeneous conditions like BBS.
The developed screening strategy enhances efficiency and cost-effectiveness for mutational analysis in Bardet-Biedl syndrome.